Work

Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases

Year: 2014

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd4422

Authors: Holger K. Eltzschig, Donna L. Bratton, Sean P. Colgan

Institutions: University of Colorado Anschutz, University of Colorado Denver, National Jewish Health

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Amphiregulin Signaling in Perioperative Cardio-Protection, Hypoxia, HIF, and Mucosal Inflammation, Hypoxia and Inflammation at the Vascular Interface, Hypoxia Inducible Factor in Acute Lung Injury, Hypoxic Adenosine Responses, Ether Lipids, Elcosanoids, and Lung Cell Pathophysiology, Extracellular Adenosine During Ventilator Induced Lung Injury, Proton Pump Inhibitors for Perioperative Acute Kidney Injury, Reversal of Inflammatory Processes in CGD, Alternative Mechanisms of Adenosine Receptor Activation, G810369885, G858021510, Indole dysbiosis and mucosal inflammation

OpenAlex ID: W2039765075

FWCI: 3.37

Cites: 233

Cited by: 366

Related to: 10